ArticleFrontiers in pharmacology2025

A real-world pharmacovigilance study of adverse drug reactions associated with lecanemab and aducanumab based on WHO-VigiAccess and FAERS databases.

Haoxiang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.